Filipe A Moura, MD, PhD(@FilipeAMoura) 's Twitter Profileg
Filipe A Moura, MD, PhD

@FilipeAMoura

Cardiology Fellow @BrighamWomens @harvardmed @TIMIStudyGroup | Alum: @WeillCornell @unicampoficial @unb_oficial Interested in cardiometabolic disease 🇧🇷🇺🇸

ID:172533554

linkhttps://connects.catalyst.harvard.edu/Profiles/display/Person/182202 calendar_today29-07-2010 23:22:22

924 Tweet

1,2K Takipçi

710 Takip Edilen

André Zimerman(@AndreZimerman) 's Twitter Profile Photo

Worth the read: new Circulation series of 2-page statistical reviews for clinicians.

Inaugural article on summarizing results of time-to-event endpoints is now published.

Couldn't think of better people than Andrea Bellavia and Sabina Murphy to lead this effort.

TIMI Study Group

account_circle
André Zimerman(@AndreZimerman) 's Twitter Profile Photo

In patients with TGs >150 mg/dL and high CV risk, apoC-III inhibitor olezarsen reduced TG levels by ~50%.

Olezarsen also reduced apoB and non-HDL-C, markers of atherogenic risk.

Proud to be a part of this team.

Full paper now in NEJM.

TIMI Study Group Brian Bergmark

In patients with TGs >150 mg/dL and high CV risk, apoC-III inhibitor olezarsen reduced TG levels by ~50%. Olezarsen also reduced apoB and non-HDL-C, markers of atherogenic risk. Proud to be a part of this team. Full paper now in @NEJM. @TIMIStudyGroup @BrianBergmark
account_circle
Sid M. Patel(@SidPatelMD) 's Twitter Profile Photo

The🧠efficacy &🩸safety of 💊 vs. in underweight or obese pts w/ remains uncertain.

👇🏽Now in Circulation, we leveraged COMBINE to perform an IPD M-A of pivotal NOAC vs. warfarin RCTs (>58k 👥) to examine 💊 effect across BMI & BW.

ahajournals.org/doi/10.1161/CI…

The🧠efficacy &🩸safety of 💊#NOAC vs. #warfarin in underweight or obese pts w/ #AF remains uncertain. 👇🏽Now in @CircAHA, we leveraged COMBINE to perform an IPD M-A of pivotal NOAC vs. warfarin RCTs (>58k 👥) to examine 💊 effect across BMI & BW. ahajournals.org/doi/10.1161/CI…
account_circle
Sid M. Patel(@SidPatelMD) 's Twitter Profile Photo

Natriuretic peptide (NP) concentrations are ⬇️ in obesity, despite obese pts having ⬆️ risk for HF.

💡What are the prognostic 📈 & Rx implications 💊 of the NP-obesity relationship for HF risk stratification?

Now from TIMI Study Group in @ESC_Journal

onlinelibrary.wiley.com/doi/10.1002/ej…

Natriuretic peptide (NP) concentrations are ⬇️ in obesity, despite obese pts having ⬆️ risk for HF. 💡What are the prognostic 📈 & Rx implications 💊 of the NP-obesity relationship for HF risk stratification? Now from @TIMIStudyGroup in @ESC_Journal onlinelibrary.wiley.com/doi/10.1002/ej…
account_circle
Marcelo Di Carli(@mdicarli) 's Twitter Profile Photo

🌟 Unlock the Power of Cardiac Imaging and join us Jan 19-21, 2024. Hands down the best course to master the latest in cardiac imaging with expert insights, case studies, and interactive hands-on learning!

🌟 Unlock the Power of Cardiac Imaging and join us Jan 19-21, 2024. Hands down the best course to master the latest in cardiac imaging with expert insights, case studies, and interactive hands-on learning! #ACCFIT #ACCImaging #CVnuc #YesCCT #YesCMR
account_circle
Siddharth Trivedi, BSc BMedS MBBS PHD FRACP FCSANZ(@SiddharthT22) 's Twitter Profile Photo

Invaluable lessons in learning, leadership & life…what an honour & privilege to be part of the Brigham cardiovascular imaging family❤️ Thank you to our esteemed faculty, technical staff, admin team, researchers & family for making it all happen, day in day out 🙏 Happy Holidays!

Invaluable lessons in learning, leadership & life…what an honour & privilege to be part of the Brigham cardiovascular imaging family❤️ Thank you to our esteemed faculty, technical staff, admin team, researchers & family for making it all happen, day in day out 🙏 Happy Holidays!
account_circle
Sergio Kaiser MD, PhD, FACC, FESC 🇧🇷🇮🇱🇷🇴🇺🇦(@pabeda1) 's Twitter Profile Photo

André Zimerman presented today at new long term safety data from Ebbinghaus srudy with on behalf of TIMI Study Group. André is a rising 🇧🇷 star, works in the 🇺🇸 and will surely make many more contributions along his career.

@AndreZimerman presented today at #AHA23 new long term safety data from Ebbinghaus srudy with #evolocumab on behalf of @TIMIStudyGroup. André is a rising 🇧🇷 star, works in the 🇺🇸 and will surely make many more contributions along his career. #CardioTwitter #Cardiology #cardioEd
account_circle
Matheus Simonato MD(@msimonatomd) 's Twitter Profile Photo

Now published in JACC Journals : large analysis from the VIVID Registry evaluating the effects of THV positioning in mitral ViV on post-procedural hemodynamics and complications.

Michael Nanna Yale Internal Medicine Yale Cardiology Mark D. Siegel icszmc

authors.elsevier.com/a/1i4wn_i2X-OU…

Now published in @JACCJournals #JACCINT: large analysis from the VIVID Registry evaluating the effects of THV positioning in mitral ViV on post-procedural hemodynamics and complications. @MichaelGNanna @YaleIMed @YaleCardiology @MarkDSiegel1 @icszmc1 authors.elsevier.com/a/1i4wn_i2X-OU…
account_circle
André Zimerman(@AndreZimerman) 's Twitter Profile Photo

Does LDL-C lowering to <40 mg/dL impair cognition over the long term?

Today at we showed, for the first time, that evolocumab + statin did NOT affect cognition up to *7.2 years*, despite LDL-C levels ~35 mg/dL.

Once again, very low LDL-C appears safe over the long term.

Does LDL-C lowering to <40 mg/dL impair cognition over the long term? Today at #AHA23 we showed, for the first time, that evolocumab + statin did NOT affect cognition up to *7.2 years*, despite LDL-C levels ~35 mg/dL. Once again, very low LDL-C appears safe over the long term.
account_circle
Sanjay Divakaran(@sanjaydivakaran) 's Twitter Profile Photo

Well said, as usual, by Robert W. Yeh MD. Perfusion PET with myocardial blood flow will continue to grow in importance to patients, interventionalists, and general cardiologists. Marcelo Di Carli Venk Murthy MD PhD

account_circle
Filipe A Moura, MD, PhD(@FilipeAMoura) 's Twitter Profile Photo

No surprises but exciting to see Eli Lilly's tirzepatide break into obesity market with FDA approval - endpts.com/eli-lillys-tir…

account_circle
Sid M. Patel(@SidPatelMD) 's Twitter Profile Photo

🧪 Lp(a) has been hypothesized to exert a pro-thrombotic effect.

💡 In a secondary prevention population, do those with ⬆️ Lp(a) derive greater benefit from prolonged DAPT with ticagrelor?

Now in JACC Journals from TIMI Study Group Michelle O'Donoghue 👇

jacc.org/doi/10.1016/j.…

🧪 Lp(a) has been hypothesized to exert a pro-thrombotic effect. 💡 In a secondary prevention population, do those with ⬆️ Lp(a) derive greater benefit from prolonged DAPT with ticagrelor? Now in @JACCJournals from @TIMIStudyGroup @DrM_ODonoghue 👇 jacc.org/doi/10.1016/j.…
account_circle
Filipe A Moura, MD, PhD(@FilipeAMoura) 's Twitter Profile Photo

Great read highlighting Svetlana Mojsov’s largely unrecognized but pivotal contributions in the discovery of GLP-1.
| Science | AAAS science.org/content/articl…

account_circle
Hasan Siddiqi(@HasanSiddiqi5) 's Twitter Profile Photo

Wonderful experience crafting this editorial on HF cardiogenic shock and PA catheters under the guidance of Dr. Lynne Stevenson and
Christopher O'Connor!
authors.elsevier.com/a/1hWwl3pkRzdp……

account_circle
Yasmin Mesquita(@yllmesquita) 's Twitter Profile Photo

It’s been a little over a month now from my first ever publication and I couldn’t thank my mentors Filipe A Moura, MD, PhD, Rhanderson Cardoso and the other co-authors enough for this great achievement!!

account_circle